Company · CIK 0001358403 · SIC 2834 — Pharmaceutical Preparations
BELLICUM PHARMACEUTICALS, INC · BLCM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2019 FForm 4 → | Feb 7, 4:02 pm EST | William GrossmanSr. VP, Chief Medical Officer | 3,126 | $3.48 | $10,878 | 26,874 | — | plan? |
| Jan 2, 2019 FMForm 4 → | Jan 4, 4:03 pm EST | Gregory S. NaeveChief Business Officer | 3,024 | $3.33 | $3,307 | 14,441 | — | plan? |
| Jan 2, 2019 FMForm 4 → | Jan 4, 4:03 pm EST | Rosemary Y. WilliamsPrincipal Accounting Officer | 2,841 | $3.28 | $2,552 | 4,471 | — | plan? |
| Jan 2, 2019 FMForm 4 → | Jan 4, 4:02 pm EST | David M. SpencerChief Technology Officer | 5,593 | $3.28 | $5,022 | 92,470 | — | plan? |
| Jan 2, 2019 FMForm 4 → | Jan 4, 4:01 pm EST | Alan K. SmithEVP, Technical Operations | 5,378 | $3.28 | $4,825 | 4,521 | — | plan? |
| Nov 9, 2018 PForm 4 → | Nov 13, 4:01 pm EST | Jon P StonehouseDirector | 10,000 | $4.56 | $45,600 | 10,000 | — | plan? |
| Sep 4, 2018 SForm 4 → | Sep 5, 4:02 pm EDT | David M. SpencerChief Technology Officer | 10,000 | $7.04 | $70,413 | 89,939 | −10.0% | plan? |
| Aug 21, 2018 FForm 4 → | Aug 23, 4:03 pm EDT | Gregory S. NaeveChief Business Officer | 1,597 | $6.74 | $10,764 | 13,403 | — | plan? |
| Jul 18, 2018 SForm 4 → | Jul 20, 4:01 pm EDT | David M. SpencerChief Technology Officer | 40,000 | $7.63 | $305,132 | 99,939 | −28.6% | plan? |
| May 29, 2018 AForm 4 → | May 29, 9:29 pm EDT | Shane WardSr. VP and General Counsel | 10,000 | — | — | 10,000 | — | plan? |
| May 25, 2018 SForm 4 → | May 29, 4:49 pm EDT | Alan A MussoCFO and Treasurer | 6,206 | $7.97 | $49,466 | 26,548 | −18.9% | plan? |
| Feb 5, 2018 AForm 4 → | Feb 7, 6:06 pm EST | William GrossmanSr. VP, Chief Medical Officer | 30,000 | — | — | 30,000 | — | plan? |
| Jan 17, 2018 SForm 4 → | Jan 19, 4:57 pm EST | BAKER BROS. ADVISORS LP +310% Owner | 880,735 | $8.20 | $7,219,895 | 58,131 | −93.8% | plan? |
| Jan 9, 2018 SForm 4 → | Jan 11, 4:02 pm EST | Alan K. SmithEVP, Technical Operations | 487 | $9.40 | $4,578 | 2,087 | −18.9% | plan? |
| Jan 3, 2018 FMForm 4 → | Jan 5, 4:04 pm EST | Alan A MussoCFO and Treasurer | 2,581 | $9.79 | $6,912 | 32,754 | — | plan? |
| Jan 3, 2018 FMForm 4 → | Jan 5, 4:03 pm EST | David M. SpencerChief Scientific Officer | 2,152 | $9.79 | $5,766 | 139,939 | — | plan? |
| Jan 3, 2018 FMForm 4 → | Jan 5, 4:03 pm EST | Alan K. SmithEVP, Technical Operations | 2,152 | $9.79 | $5,766 | 2,574 | — | plan? |
| Jan 3, 2018 FMForm 4 → | Jan 5, 4:03 pm EST | Ken MoseleySr. VP and General Counsel | 2,152 | $9.79 | $5,766 | 1,465 | — | plan? |
| Dec 11, 2017 SForm 4 → | Dec 13, 4:05 pm EST | Alan A MussoCFO and Treasurer | 17,117 | $9.33 | $159,667 | 31,585 | −35.1% | plan? |
| Nov 27, 2017 SForm 4 → | Nov 29, 5:06 pm EST | Alan A MussoCFO and Treasurer | 6,206 | $9.89 | $61,382 | 48,702 | — | plan? |
| Aug 21, 2017 AForm 4 → | Aug 23, 6:46 pm EDT | Gregory S. NaeveSr. VP, Chief Business Officer | 15,000 | — | — | 15,000 | — | plan? |
| Jul 24, 2017 SForm 4 → | Jul 26, 4:29 pm EDT | Alan K. SmithEVP, Technical Operations | 437 | $11.85 | $5,178 | 1,600 | −21.5% | plan? |
| Jul 13, 2017 SForm 4 → | Jul 17, 4:20 pm EDT | Ken MoseleySr. VP and General Counsel | 13,823 | $12.26 | $169,470 | 491 | −96.6% | plan? |
| Jul 13, 2017 MForm 4 → | Jul 17, 4:20 pm EDT | Ken MoseleySr. VP and General Counsel | 13,823 | $2.55 | $35,249 | 14,314 | — | plan? |
| Jul 10, 2017 SForm 4 → | Jul 12, 4:43 pm EDT | David M. SpencerChief Scientific Officer | 10,000 | $11.54 | $115,400 | 138,965 | −6.71% | plan? |
| May 25, 2017 SForm 4 → | May 26, 3:07 pm EDT | Alan A MussoCFO and Treasurer | 6,311 | $12.24 | $77,254 | 54,908 | −10.3% | plan? |
| Mar 24, 2017 PForm 4 → | Mar 28, 5:05 pm EDT | BAKER BROS. ADVISORS LP +310% Owner | 166,666 | $12.00 | $1,999,992 | 4,527,089 | +3.82% | plan? |
| Feb 7, 2017 SForm 4 → | Feb 9, 4:11 pm EST | Kevin M. SlawinDirector | 30,000 | $12.54 | $376,215 | 294,982 | −9.23% | plan? |
| Dec 15, 2016 SForm 4 → | Dec 19, 4:13 pm EST | Kevin M. SlawinChief Technology Officer, Director | 30,000 | $15.45 | $463,539 | 324,982 | −8.45% | plan? |
| Dec 5, 2016 SForm 4 → | Dec 5, 6:42 pm EST | David M. SpencerChief Scientific Officer | 5,000 | $20.00 | $100,000 | 146,082 | −3.31% | plan? |
| Dec 1, 2016 SForm 4 → | Dec 5, 4:09 pm EST | David M. SpencerChief Scientific Officer | 5,000 | $17.52 | $87,624 | 151,082 | −3.20% | plan? |
| Dec 1, 2016 SForm 4 → | Dec 5, 4:07 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 25,000 | $17.54 | $438,505 | 442 | −98.3% | plan? |
| Dec 1, 2016 MForm 4 → | Dec 5, 4:07 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 25,000 | $2.55 | $63,750 | 25,442 | — | plan? |
| Nov 25, 2016 SForm 4 → | Nov 29, 4:05 pm EST | Alan A MussoCFO and Treasurer | 29,300 | $19.51 | $571,641 | 60,548 | −32.6% | plan? |
| Sep 21, 2016 SForm 4 → | Sep 23, 6:57 pm EDT | David M. SpencerChief Scientific Officer | 16,500 | $19.88 | $328,016 | 156,082 | −9.56% | plan? |
| Sep 21, 2016 SForm 4 → | Sep 23, 6:56 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 23,416 | $20.12 | $471,088 | 354,982 | −6.19% | plan? |
| Sep 21, 2016 SForm 4 → | Sep 23, 6:55 pm EDT | Ken MoseleySr. VP and General Counsel | 11,800 | $20.10 | $237,202 | 344 | −97.2% | plan? |
| Sep 21, 2016 MForm 4 → | Sep 23, 6:55 pm EDT | Ken MoseleySr. VP and General Counsel | 11,800 | $7.47 | $88,146 | 12,044 | — | plan? |
| Sep 16, 2016 SForm 4 → | Sep 20, 6:21 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 4,584 | $20.01 | $91,713 | 367,040 | −1.23% | plan? |
| Sep 16, 2016 SForm 4 → | Sep 20, 6:20 pm EDT | David M. SpencerChief Scientific Officer | 2,500 | $20.01 | $50,028 | 172,582 | −1.43% | plan? |
| Sep 16, 2016 SForm 4 → | Sep 20, 6:19 pm EDT | Ken MoseleySr. VP and General Counsel | 2,200 | $20.01 | $44,018 | 344 | −86.5% | plan? |
| Sep 16, 2016 MForm 4 → | Sep 20, 6:19 pm EDT | Ken MoseleySr. VP and General Counsel | 2,200 | $7.47 | $16,434 | 544 | — | plan? |
| Aug 15, 2016 SForm 4 → | Aug 17, 4:11 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 67,000 | $19.31 | $1,293,943 | 368,982 | −15.4% | plan? |
| Aug 15, 2016 SForm 4 → | Aug 17, 4:09 pm EDT | David M. SpencerChief Scientific Officer | 1,000 | $20.00 | $20,000 | 175,082 | −0.57% | plan? |
| Aug 15, 2016 SForm 4 → | Aug 17, 4:09 pm EDT | Ken MoseleySr. VP and General Counsel | 1,000 | $20.00 | $20,000 | 344 | −74.4% | plan? |
| Aug 15, 2016 MForm 4 → | Aug 17, 4:09 pm EDT | Ken MoseleySr. VP and General Counsel | 1,000 | $7.47 | $7,470 | 1,344 | — | plan? |
| Jul 27, 2016 SForm 4 → | Jul 29, 5:50 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 15,000 | $15.00 | $225,000 | 399,982 | −3.61% | plan? |
| Jul 27, 2016 SForm 4 → | Jul 29, 5:48 pm EDT | David M. SpencerChief Scientific Officer | 10,000 | $15.00 | $150,000 | 176,082 | −5.37% | plan? |
| Jul 18, 2016 SForm 4 → | Jul 19, 6:42 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 2,719 | $13.99 | $38,044 | 134,206 | −1.99% | plan? |
| Jul 15, 2016 SForm 4 → | Jul 19, 4:02 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 22,281 | $13.72 | $305,677 | 136,925 | −14.0% | plan? |
| Jun 2, 2016 SForm 4 → | Jun 6, 4:06 pm EDT | Annemarie MoseleyCOO/EVP Clinical Development | 25,000 | $13.00 | $325,000 | 251 | −99.0% | plan? |
| Jun 2, 2016 MForm 4 → | Jun 6, 4:06 pm EDT | Annemarie MoseleyCOO/EVP Clinical Development | 25,000 | $2.55 | $63,750 | 7,016 | — | plan? |
| Jun 2, 2016 SForm 4 → | Jun 6, 4:06 pm EDT | Ken MoseleySr. VP and General Counsel | 15,000 | $13.00 | $195,000 | 196 | −98.7% | plan? |
| Jun 2, 2016 MForm 4 → | Jun 6, 4:06 pm EDT | Ken MoseleySr. VP and General Counsel | 15,000 | $2.55 | $38,250 | 15,196 | — | plan? |
| Apr 22, 2016 SForm 4 → | Apr 26, 4:06 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 55,000 | $11.43 | $628,498 | 414,982 | −11.7% | plan? |
| Jan 4, 2016 SForm 4 → | Jan 6, 4:20 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 35,000 | $19.07 | $667,494 | 251 | −99.3% | plan? |
| Jan 4, 2016 MForm 4 → | Jan 6, 4:20 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 35,000 | $2.55 | $89,250 | 35,251 | — | plan? |
| Dec 14, 2015 MForm 4 → | Dec 16, 4:04 pm EST | David M. SpencerChief Scientific Officer | 5,000 | $2.55 | $12,750 | 184,559 | — | plan? |
| Dec 1, 2015 SForm 4 → | Dec 3, 4:16 pm EST | David M. SpencerChief Scientific Officer | 5,000 | $22.95 | $114,739 | 178,600 | −2.72% | plan? |
| Nov 24, 2015 SForm 4 → | Nov 27, 4:50 pm EST | Alan A MussoCFO and Treasurer | 29,300 | $22.34 | $654,459 | 88,742 | −24.8% | plan? |
| Nov 16, 2015 SForm 4 → | Nov 18, 11:44 am EST | Kevin M. SlawinChief Technology Officer, Director | 24,000 | $20.65 | $495,509 | 398,066 | −5.69% | plan? |
| Nov 2, 2015 SForm 4 → | Nov 4, 1:36 pm EST | Ken MoseleySr. VP and General Counsel | 15,000 | $13.00 | $195,000 | 97 | −99.4% | plan? |
| Nov 2, 2015 MForm 4 → | Nov 4, 1:36 pm EST | Ken MoseleySr. VP and General Counsel | 15,000 | $2.55 | $38,250 | 15,097 | — | plan? |
| Oct 1, 2015 SForm 4 → | Oct 6, 6:11 am EDT | Thomas J. FarrellPresident and CEO, Director | 2,500 | $14.58 | $36,442 | 63,862 | −3.77% | plan? late |
| Sep 21, 2015 MForm 4 → | Sep 23, 5:14 pm EDT | David M. SpencerChief Scientific Officer | 5,000 | $2.55 | $12,750 | 183,600 | — | plan? |
| Sep 11, 2015 SForm 4 → | Sep 15, 4:11 pm EDT | David M. SpencerChief Scientific Officer | 5,000 | $19.00 | $95,000 | 178,600 | −2.72% | plan? |
| Sep 1, 2015 SForm 4 → | Sep 3, 4:55 pm EDT | Thomas J. FarrellPresident and CEO, Director | 2,500 | $16.78 | $41,943 | 66,362 | −3.63% | plan? |
| Aug 3, 2015 SForm 4 → | Aug 5, 5:07 pm EDT | Thomas J. FarrellPresident and CEO, Director | 2,500 | $20.24 | $50,608 | 68,862 | −3.50% | plan? |
| Jul 15, 2015 SForm 4 → | Jul 17, 4:59 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 6,000 | $20.00 | $120,000 | 402,066 | −1.47% | plan? |
| Jul 2, 2015 MForm 4 → | Jul 7, 4:59 pm EDT | David M. SpencerChief Scientific Officer | 20,000 | $2.55 | $51,000 | 183,600 | — | plan? |
| Jul 1, 2015 SForm 4 → | Jul 6, 5:00 pm EDT | Ken MoseleySr. VP and General Counsel | 15,000 | $20.62 | $309,267 | 97 | −99.4% | plan? |
| Jul 1, 2015 MForm 4 → | Jul 6, 5:00 pm EDT | Ken MoseleySr. VP and General Counsel | 15,000 | $2.55 | $38,250 | 15,097 | — | plan? |
| Jul 1, 2015 SForm 4 → | Jul 6, 4:59 pm EDT | Annemarie MoseleyCOO/EVP Clinical Development | 35,000 | $20.62 | $721,622 | 122 | −99.7% | plan? |
| Jul 1, 2015 MForm 4 → | Jul 6, 4:59 pm EDT | Annemarie MoseleyCOO/EVP Clinical Development | 35,000 | $2.55 | $89,250 | 35,122 | — | plan? |
| Jun 16, 2015 SForm 4/A → | Jun 19, 5:06 pm EDT | David M. SpencerChief Scientific Officer | 20,000 | $22.96 | $459,173 | 163,600 | −10.9% | plan? |
| Jun 16, 2015 SForm 4 → | Jun 18, 5:03 pm EDT | David M. SpencerChief Scientific Officer | 20,000 | $22.96 | $459,173 | 162,754 | −10.9% | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 AForm 4 → | Feb 5, 4:12 pm EST | Gregory S. NaeveChief Business Officer | 75,000 | — | — | 75,000 | — | |
| Feb 1, 2019 AForm 4 → | Feb 5, 4:11 pm EST | Alan K. SmithEVP, Technical Operations | 75,000 | — | — | 75,000 | — | |
| Feb 1, 2019 AForm 4 → | Feb 5, 4:10 pm EST | David M. SpencerChief Technology Officer | 15,000 | — | — | 15,000 | — | |
| Feb 1, 2019 AForm 4 → | Feb 5, 4:10 pm EST | Richard A. FairPresident and CEO, Director | 300,000 | — | — | 300,000 | — | |
| Feb 1, 2019 AForm 4 → | Feb 5, 4:09 pm EST | Shane WardSr. VP and General Counsel | 45,000 | — | — | 45,000 | — | |
| Feb 1, 2019 AForm 4 → | Feb 5, 4:09 pm EST | William GrossmanSr. VP, Chief Medical Officer | 82,500 | — | — | 82,500 | — | |
| Feb 1, 2019 AForm 4 → | Feb 5, 4:08 pm EST | Rosemary Y. WilliamsPrincipal Accounting Officer | 25,000 | — | — | 25,000 | — | |
| Jan 2, 2019 MForm 4 → | Jan 4, 4:03 pm EST | Gregory S. NaeveChief Business Officer | 2,031 | — | — | 6,094 | — | |
| Jan 2, 2019 MForm 4 → | Jan 4, 4:03 pm EST | Rosemary Y. WilliamsPrincipal Accounting Officer | 2,063 | — | — | 1,562 | — | |
| Jan 2, 2019 MForm 4 → | Jan 4, 4:02 pm EST | David M. SpencerChief Technology Officer | 4,062 | — | — | 3,125 | — | |
| Jan 2, 2019 MForm 4 → | Jan 4, 4:01 pm EST | Alan K. SmithEVP, Technical Operations | 3,906 | — | — | 3,125 | — | |
| Dec 20, 2018 AForm 4 → | Dec 20, 9:23 pm EST | Judith V KlimovskyDirector | 62,500 | — | — | 12,500 | — | |
| Dec 19, 2018 AForm 4 → | Dec 20, 9:14 pm EST | Atabak MokariSr. VP and CFO | 300,000 | — | — | 300,000 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:03 pm EDT | Alan A MussoCFO and Treasurer | 52,500 | — | — | 52,500 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:03 pm EDT | David M. SpencerChief Technology Officer | 42,000 | — | — | 42,000 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:03 pm EDT | Gregory S. NaeveChief Business Officer | 34,125 | — | — | 34,125 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:02 pm EDT | Richard A. FairPresident and CEO, Director | 225,000 | — | — | 225,000 | — | |
| Jul 2, 2018 AForm 4 → | Jul 5, 4:02 pm EDT | Alan K. SmithEVP, Technical Operations | 39,375 | — | — | 39,375 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:33 pm EDT | Frank B. McGuyerDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:33 pm EDT | Stephen DavisDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:32 pm EDT | James F BrownDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:32 pm EDT | James M DalyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:31 pm EDT | Reid M HuberDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:31 pm EDT | Jon P StonehouseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 18, 4:30 pm EDT | Edmund HarriganDirector | 10,000 | — | — | 10,000 | — | |
| May 29, 2018 AForm 4 → | May 29, 9:29 pm EDT | Shane WardSr. VP and General Counsel | 120,000 | — | — | 120,000 | — | |
| Feb 20, 2018 AForm 4 → | Feb 22, 4:04 pm EST | Edmund HarriganDirector | 23,166 | — | — | 23,166 | — | |
| Feb 5, 2018 AForm 4 → | Feb 7, 6:06 pm EST | William GrossmanSr. VP, Chief Medical Officer | 175,000 | — | — | 175,000 | — | |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:04 pm EST | Alan A MussoCFO and Treasurer | 1,875 | — | — | 5,625 | — | |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:03 pm EST | David M. SpencerChief Scientific Officer | 1,563 | — | — | 4,687 | — | |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:03 pm EST | Alan K. SmithEVP, Technical Operations | 1,563 | — | — | 4,687 | — | |
| Jan 3, 2018 MForm 4 → | Jan 5, 4:03 pm EST | Ken MoseleySr. VP and General Counsel | 1,563 | — | — | 4,687 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:03 pm EST | Richard A. FairPresident and CEO, Director | 225,000 | — | — | 225,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:02 pm EST | David M. SpencerChief Scientific Officer | 28,000 | — | — | 10,000 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:02 pm EST | Gregory S. NaeveSr. VP, Chief Business Officer | 22,750 | — | — | 8,125 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:02 pm EST | Alan K. SmithEVP, Technical Operations | 26,250 | — | — | 9,375 | — | |
| Jan 2, 2018 AForm 4 → | Jan 4, 4:01 pm EST | Alan A MussoCFO and Treasurer | 35,000 | — | — | 12,500 | — | |
| Aug 21, 2017 AForm 4 → | Aug 23, 6:46 pm EDT | Gregory S. NaeveSr. VP, Chief Business Officer | 130,000 | — | — | 130,000 | — | |
| Jul 13, 2017 MForm 4 → | Jul 17, 4:20 pm EDT | Ken MoseleySr. VP and General Counsel | 13,823 | — | — | 0 | — | |
| Jul 3, 2017 AForm 4 → | Jul 6, 4:14 pm EDT | David M. SpencerChief Scientific Officer | 26,250 | — | — | 26,250 | — | |
| Jul 3, 2017 AForm 4 → | Jul 6, 4:13 pm EDT | Ken MoseleySr. VP and General Counsel | 68,250 | — | — | 42,000 | — | |
| Jul 3, 2017 AForm 4 → | Jul 6, 4:10 pm EDT | Alan K. SmithEVP, Technical Operations | 26,250 | — | — | 26,250 | — | |
| Jul 3, 2017 AForm 4 → | Jul 6, 4:09 pm EDT | Alan A MussoCFO and Treasurer | 31,500 | — | — | 31,500 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:44 pm EDT | Jon P StonehouseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:43 pm EDT | Kevin M. SlawinDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:41 pm EDT | Frank B. McGuyerDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:39 pm EDT | Reid M HuberDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:36 pm EDT | Stephen DavisDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:35 pm EDT | James M DalyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 4:34 pm EDT | James F BrownDirector | 10,000 | — | — | 10,000 | — | |
| May 10, 2017 AForm 4 → | May 12, 7:56 pm EDT | Alan K. SmithEVP, Technical Oprations | 20,000 | — | — | 20,000 | — | |
| Jan 30, 2017 AForm 4 → | Feb 1, 4:11 pm EST | Richard A. FairPresident and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:18 pm EST | Ken MoseleySr. VP and General Counsel | 17,500 | — | — | 6,250 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:18 pm EST | Peter L. HoangSr. VP of Bus. Development | 17,500 | — | — | 6,250 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:17 pm EST | David M. SpencerChief Scientific Officer | 17,500 | — | — | 6,250 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:16 pm EST | Alan A MussoCFO and Treasurer | 21,000 | — | — | 7,500 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:15 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 28,000 | — | — | 10,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 5, 7:14 pm EST | Thomas J. FarrellPresident and CEO, Director | 75,250 | — | — | 26,875 | — | |
| Dec 1, 2016 MForm 4 → | Dec 5, 4:07 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 25,000 | — | — | 27,058 | — | |
| Sep 21, 2016 MForm 4 → | Sep 23, 6:55 pm EDT | Ken MoseleySr. VP and General Counsel | 11,800 | — | — | 29,117 | — | |
| Sep 16, 2016 MForm 4 → | Sep 20, 6:19 pm EDT | Ken MoseleySr. VP and General Counsel | 2,200 | — | — | 40,917 | — | |
| Aug 15, 2016 MForm 4 → | Aug 17, 4:09 pm EDT | Ken MoseleySr. VP and General Counsel | 1,000 | — | — | 43,117 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 4:14 pm EDT | Jon P StonehouseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 4:14 pm EDT | Frank B. McGuyerDirector | 10,000 | — | — | 10,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 4:12 pm EDT | Reid M HuberDirector | 10,000 | — | — | 10,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 4:12 pm EDT | Stephen DavisDirector | 10,000 | — | — | 10,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 4:11 pm EDT | James M DalyDirector | 10,000 | — | — | 10,000 | — | |
| Jun 15, 2016 AForm 4 → | Jun 17, 4:10 pm EDT | James F BrownDirector | 10,000 | — | — | 10,000 | — | |
| Jun 2, 2016 MForm 4 → | Jun 6, 4:06 pm EDT | Annemarie MoseleyCOO/EVP Clinical Development | 25,000 | — | — | 52,058 | — | |
| Jun 2, 2016 MForm 4 → | Jun 6, 4:06 pm EDT | Ken MoseleySr. VP and General Counsel | 15,000 | — | — | 13,823 | — | |
| May 17, 2016 AForm 4 → | May 19, 4:01 pm EDT | James M DalyDirector | 20,833 | — | — | 833 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:25 pm EST | David M. SpencerChief Scientific Officer | 60,000 | — | — | 60,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:23 pm EST | Alan A MussoCFO and Treasurer | 60,000 | — | — | 60,000 | — | |
| Jan 4, 2016 AMForm 4 → | Jan 6, 4:20 pm EST | Annemarie MoseleyCOO/EVP Clinical Development | 160,000 | — | — | 18,235 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:17 pm EST | Ken MoseleySr. VP and General Counsel | 37,500 | — | — | 37,500 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:14 pm EST | Kevin M. SlawinChief Technology Officer, Director | 60,000 | — | — | 60,000 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:11 pm EST | Peter L. HoangSr. VP of Bus. Development | 37,500 | — | — | 37,500 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 4:05 pm EST | Thomas J. FarrellPresident and CEO, Director | 160,000 | — | — | 160,000 | — | |
| Dec 14, 2015 MForm 4 → | Dec 16, 4:04 pm EST | David M. SpencerChief Scientific Officer | 5,000 | — | — | 117,058 | — | |
| Nov 2, 2015 MForm 4 → | Nov 4, 1:36 pm EST | Ken MoseleySr. VP and General Counsel | 15,000 | — | — | 28,823 | — | |
| Sep 21, 2015 MForm 4 → | Sep 23, 5:14 pm EDT | David M. SpencerChief Scientific Officer | 5,000 | — | — | 122,058 | — | |
| Jul 13, 2015 AForm 4 → | Jul 15, 5:51 pm EDT | Stephen DavisDirector | 29,167 | — | — | 9,167 | — | |
| Jul 2, 2015 MForm 4 → | Jul 7, 4:59 pm EDT | David M. SpencerChief Scientific Officer | 20,000 | — | — | 127,058 | — | |
| Jul 1, 2015 MForm 4 → | Jul 6, 5:00 pm EDT | Ken MoseleySr. VP and General Counsel | 15,000 | — | — | 43,823 | — | |
| Jul 1, 2015 MForm 4 → | Jul 6, 4:59 pm EDT | Annemarie MoseleyCOO/EVP Clinical Development | 35,000 | — | — | 53,235 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 5:05 pm EDT | Jon P StonehouseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 5:04 pm EDT | Frank B. McGuyerDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 5:03 pm EDT | Reid M HuberDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 5:02 pm EDT | James F BrownDirector | 10,000 | — | — | 10,000 | — | |
| Mar 6, 2015 AForm 4 → | Mar 9, 1:11 pm EDT | Kevin M. SlawinChief Technology Officer, Director | 60,000 | — | — | 60,000 | — | |
| Mar 6, 2015 AForm 4 → | Mar 9, 1:09 pm EDT | Annemarie MoseleyChief Operating Office and EVP | 100,000 | — | — | 100,000 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 6:33 pm EST | Joseph SenesacVP of Manufacturing | 20,000 | — | — | 20,000 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 6:31 pm EST | Peter L. HoangSr. VP of Bus. Development | 60,000 | — | — | 60,000 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 6:29 pm EST | Ken MoseleyVice President | 60,000 | — | — | 60,000 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 6:25 pm EST | David M. SpencerChief Scientific Officer | 60,000 | — | — | 60,000 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 6:20 pm EST | Alan A MussoCFO and Treasurer | 60,000 | — | — | 60,000 | — | |
| Feb 24, 2015 AForm 4 → | Feb 26, 6:19 pm EST | Thomas J. FarrellPresident and CEO, Director | 160,000 | — | — | 160,000 | — |